메뉴 건너뛰기




Volumn 167, Issue 20, 2005, Pages 2143-2146

Classical pharmacogenetics;Klassisk farmakogenetik

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLURIC ACID; 1 METHYLXANTHINE; 1,7 DIMETHYLURIC ACID; 5 ACETAMIDO 6 FORMYLAMINO 3 METHYLURACIL; CHOLINESTERASE; CODEINE; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; DEBRISOQUINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LANSOPRAZOLE; MEPHENYTOIN; NEUROLEPTIC AGENT; OMEPRAZOLE; PROGUANIL; PROTON PUMP INHIBITOR; SPARTEINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

EID: 20344384559     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey
Times cited : (5)

References (9)
  • 1
    • 0015827962 scopus 로고
    • Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: The role of genetic factors
    • Andreasen PB, Froland A, Skovsted L et al. Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: the role of genetic factors. Acta Med Scand 1973;193:561-4.
    • (1973) Acta Med Scand , vol.193 , pp. 561-564
    • Andreasen, P.B.1    Froland, A.2    Skovsted, L.3
  • 2
    • 0036667961 scopus 로고    scopus 로고
    • The interindividual differences in the 3-demetnylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors
    • Rasmussen BB, Brix TH, Kyvik KO et al. The interindividual differences in the 3-demetnylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 2002;12:473-8.
    • (2002) Pharmacogenetics , vol.12 , pp. 473-478
    • Rasmussen, B.B.1    Brix, T.H.2    Kyvik, K.O.3
  • 3
    • 0037328994 scopus 로고    scopus 로고
    • Pharmacogenetics of the major polymorphic metabolizing enzymes
    • Daly AK. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fund Clin Pharmacol 2003;17:27-41.
    • (2003) Fund Clin Pharmacol , vol.17 , pp. 27-41
    • Daly, A.K.1
  • 4
    • 0021359919 scopus 로고
    • Individuelle variationer i lægemidlers oksidative metabolisme
    • Brøsen K. Individuelle variationer i lægemidlers oksidative metabolisme. Ugeskr Læger 1984;13:955-9.
    • (1984) Ugeskr Læger , vol.13 , pp. 955-959
    • Brøsen, K.1
  • 5
    • 20344381445 scopus 로고    scopus 로고
    • aug
    • http://www.imm.ki.se/CYPalleles /aug 2004.
    • (2004)
  • 6
    • 3142519666 scopus 로고    scopus 로고
    • Pharmacogenetics of antidepressants and antipsychotics: The contribution of alleleic variations to the phenotype of drug response
    • Kirchheiner J, Nickchen K, Bauer M et al. Pharmacogenetics of antidepressants and antipsychotics: the contribution of alleleic variations to the phenotype of drug response. Molecular Psychiatry 2004;9:442-73.
    • (2004) Molecular Psychiatry , vol.9 , pp. 442-473
    • Kirchheiner, J.1    Nickchen, K.2    Bauer, M.3
  • 8
    • 12344334846 scopus 로고    scopus 로고
    • Clinical aspects of the MDR1 (ABCB1) gene polymorphism
    • Eichelbaum M, Fromm MF, Schwab M. Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther D Monit 2004;25:180-5.
    • (2004) Ther D Monit , vol.25 , pp. 180-185
    • Eichelbaum, M.1    Fromm, M.F.2    Schwab, M.3
  • 9
    • 0024359574 scopus 로고
    • Clinical significance of the sparteine/debrisoquine oxidation polymorphism
    • Brøsen K, Gram LF. Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur J Clin Pharmacol 1989;36:537-47.
    • (1989) Eur J Clin Pharmacol , vol.36 , pp. 537-547
    • Brøsen, K.1    Gram, L.F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.